Chronic hepatitis C beta-interferon-induced severe hypertriglyceridaemia with apolipoprotein E phenotype E3/2

International Journal of Clinical Practice

Volumn 54, Issue 4, 2000, Pages

  Homma, Yasuhiko ^a   Kawazoe, K ^a   Ito, T ^b   Ide, H ^b   Takahashi, H ^b   Ueno, F ^b   Matsuzaki, S ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY OISO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; BETA INTERFERON; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ADULT; ARTICLE; CALORIC INTAKE; CASE REPORT; CHOLESTEROL BLOOD LEVEL; ENZYME INHIBITION; HEPATITIS C; HUMAN; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN BLOOD LEVEL; LOW FAT DIET; LYMPHOCYTE; MALE; PHENOTYPE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; APOLIPOPROTEINS E; DIET, FAT-RESTRICTED; ENERGY INTAKE; HEPATITIS C; HUMANS; HYPERTRIGLYCERIDEMIA; INTERFERON-BETA; LIPOPROTEINS; MALE; TRIGLYCERIDES;

EID: 0343618422     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Havel RJ, Kane JP. Introduction: structure and metabolism of plasma lipoproleins. In: Scriver CR, Beaudct AL, Sly WS et al, Eds. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 1995; 1841-1852.
2. Brunzell JD. Familial lipoprotein lipase deficiency and other causes of the chylomicron syndrome. In: Scriver CR, Beaidet AL, Sly WS et al, Eds. The metabolic and molecular hases of inherited disease. New York: McGraw-Hill, 1995; 1913-1932.
3. Ehnholm C, Aho K, Huttunen JK et al. Effect of interferon on plasma lipoprotcins and on the activity of postheparin plasma lipases. Arteriosclerosis 1982; 2: 68-73.
4. Kurzrock R, Rohde MF, Onesada JR et al. Recombinant interferon induces hypertriglyceridemic and inhibits post-heparin lipase activity in cancer patients. J Exp Med 1986; 164: 1093-1101.
5. Massaro ER, Borden EC, Howkins MJ et al. Effects of recombinant interferon-alpha treatment upon lipid concentration and lipoprotein composition. J Interferon Res 1986; 6: 655-662.
6. Rosenzweig IB, Wiehe DA, Borden EL et al. Plasma lipoprotein changes in humans induced by β-interferon. Atherosclerosis 1987; 67: 261-267.
7. Grunfeld C, Feingold KR. The role of the cytokines, interferon-alpha and tumor necrosis factor in the hypertriglyceridemia and wasting of AIDS. J Nitlr 1992; 122: 749-753.
8. Sunderkotter C, Luger T, Kolde G. Severe hypertriglyceridaemia and interferon-α. Lancet 1993; 392: 1111.
9. Graessle D, Bonacini M, Chen S. Alpha-interferon and reversible hypertriglyceridemia. Ann Int Med 1993; 118: 316-317.
10. Feingald KR, Marshall M. Gulli R et al. Effect of endotoxin and cytokines on lipoprotein lipase activity in mice. Arterioscler Thromb 1994; 14: 1866-1872.
11. Yamagishi S, Abe T, Sawada T. Human recombinant Interferon α-2a (IFN a-2a) therapy suppresses hepatic triglyceride lipase, leading to severe hypertriglyceridemia in a diabetic patient. Am J Gastroenterol 1994; 89: 2280.
12. Shinohara E, Yamashita S, Kihara S et al. Interferon alpha induces disorder of lipid metabolism by lowering postheparin lipases and cholesteryl ester transfer protein activities in patients with chronic hepatitis C Hepatology 1997; 25: 1502-1506.
13. Fernandes-Miranda C, Castellano G, Guijarro C et al. Lipoprotein changes in patients with chronic hapatitis C treated with interferon-α. Am J Gastroenterol 1998; 93: 1901-1904.
14. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988; 8: 1-12.
15. Mahley RW, Rall SC. The type III hyperlipoproteinemia (dysbetalipoproteinemia): The role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: Scriver CR, Beaudet AL, Sly WS et al, Eds. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill, 1995; 1953-1980.
16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
17. Noma A, Hata Y, Goto Y. Quantification of serum apolipoprotein A-I, A-II, B, C-II, C-III, and E in healthy Japanese by turbidimetric immunoassay; reference values and age-and sex-related difference. Clin Clim Acta 1991; 199: 147-158.
18. Burstein M, Scholnick HR, Morfin R. Rapid method for isolation of lipoproteins from human plasma. J Lip Res 1970; 11: 583-595.
19. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34: 1545-1553.
20. Homma Y, Moriguchi EH, Sakane H et al. Effects of probucol on plasma lipoprotein subfractions and activities of lipoprotein lipase and hepatic triglyceride lipase. Atherosclerosis 1991; 88: 175-181.
21. Ikeda Y, Takagi A, Ohhara Y et al. A sandwich-enzyme immunoassay for the quantification of lipoprotein lipase and hepatic triglyceride lipase in post-heparin plasma using monoclonal antibodies to the corresponding enzymes. J Lipid Res 1990; 31: 1991-1924.
22. Kataoka S, Paichi N, Howard BV. Simplified isoelectric focusing immunoblotting determination of apoprotein E phenotype. Clin Chem 1994; 40: 11-13.
23. Ranganathan S, Hattori H, Kashyap ML. A rapid flow cytometric assay fow low-density lipoprotein receptors in human blood mononuclear cells. J Lab Clin Med 1995; 125: 479-486.
24. Kojima S, Homma Y, Sakane H et al. A case of moderate hypertriglyceridemia with apolipoprotein E phenotype E4/3. Tokai J Exp Clin Med 1996; 21: 165-169.
25. Homma Y, Kobayashi T, Sakane H et al. Unusual case of normotriglyceridemia with elevated plasma levels of apolipoprotein CII, CIII, and E. Nutr Met Cardiovasc Dis 1997; 7: 25-29.
26. Albers JJ, Tollefson JH, Chen C-H et al. Isolation and characterization of human lipid transfer protein. Arteriosclerosis 1984; 4: 49-58.
27. Tall AR. Plasma high density lipoproteins: metabolism and relationship to atherogenesis. J Clin Invest 1990; 86: 379-384.
28. Applibaum-Bowden D. Lipases and lecithin: cholesterol acyltransferase in the control of lipoprotein metabolism. Curr Opn Lipidol 1995; 6: 130-135.
29. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res 1995; 36: 211-228.
30. Grandy SM, Denke MA. Dietary influences on serum lipids and lipoproteins. J Lipid Res 1990; 31: 1149-1172.